AVE 33.3% 0.2¢ avecho biotechnology limited

three months on...., page-47

  1. 5,794 Posts.
    lightbulb Created with Sketch. 735
    Say what you want about the company kwad, but why bag hottod, because of your poor judgement years ago.
    Not everyone sharing their knowledge and research is out to get you. You've been watching too many conspiracy movies.

    In regards to the company, no one could have foretold esragate, and please don't suggest that it could have been. Not withstanding this, crystallisation was the only clinical hurdle in our transdermal delivery aspirations. It happens. It was fixed.
    Would we be 8c without esra gate, I doubt it, but it's irrelevant as esragate did occur and now we are suffering the consequences.
    It has been too much for many, but not the top 20 holders, so we sit tight and hope that clinical success will get us back on track.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.